Literature DB >> 11901245

Subcortical vascular dementia.

Timo Erkinjuntti1.   

Abstract

Vascular dementia (VaD) incorporates different vascular mechanisms and changes in the brain, and has different causes and clinical manifestations. Current criteria for VaD select an aetiologically and clinically heterogeneous group and this definitional heterogeneity has affected clinical trial results. Focus on a more homogeneous group, such as that with subcortical (ischaemic) VaD, could be an alternative in clinical drug trials. This subtype incorporates two small vessel clinical entities - 'Binswanger's disease' and 'the lacunar state'. It comprises small vessel disease as the primary vascular aetiology, lacunar infarct(s) and ischaemic white matter lesions as the primary type of brain lesions, subcortical location as the primary location of lesions, and the subcortical clinical syndrome as the primary clinical manifestation. Subcortical VaD is expected to show a more predictable clinical picture, natural history, outcome and treatment responses. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 11901245     DOI: 10.1159/000049152

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  21 in total

1.  Cognitive profile of subcortical ischaemic vascular disease.

Authors:  H Jokinen; H Kalska; R Mäntylä; T Pohjasvaara; R Ylikoski; M Hietanen; O Salonen; M Kaste; T Erkinjuntti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

Review 2.  Distinguishing Alzheimer's disease from other major forms of dementia.

Authors:  Stella Karantzoulis; James E Galvin
Journal:  Expert Rev Neurother       Date:  2011-11       Impact factor: 4.618

3.  Diffusion tensor imaging of the hippocampus and verbal memory performance: the RUN DMC study.

Authors:  Anouk G W van Norden; Karlijn F de Laat; Ilma Fick; Inge W M van Uden; Lucas J B van Oudheusden; Rob A R Gons; David G Norris; Marcel P Zwiers; Roy P C Kessels; Frank-Erik de Leeuw
Journal:  Hum Brain Mapp       Date:  2011-03-09       Impact factor: 5.038

4.  Morphometry demonstrates loss of cortical thickness in cerebral microangiopathy.

Authors:  Christoph Preul; Gabriele Lohmann; Margret Hund-Georgiadis; Thomas Guthke; D Yves von Cramon
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

5.  Pseudobulbar paralysis in the Renaissance: Cosimo I de' Medici case.

Authors:  F Arba; D Inzitari; D Lippi
Journal:  Neurol Sci       Date:  2014-03-07       Impact factor: 3.307

6.  Diffusion tensor imaging of the hippocampus predicts the risk of dementia; the RUN DMC study.

Authors:  I W M van Uden; A M Tuladhar; H M van der Holst; E M C van Leijsen; A G W van Norden; K F de Laat; L C A Rutten-Jacobs; D G Norris; J A H R Claassen; E J van Dijk; R P C Kessels; F-E de Leeuw
Journal:  Hum Brain Mapp       Date:  2015-10-15       Impact factor: 5.038

7.  Structural network connectivity and cognition in cerebral small vessel disease.

Authors:  Anil M Tuladhar; Ewoud van Dijk; Marcel P Zwiers; Anouk G W van Norden; Karlijn F de Laat; Elena Shumskaya; David G Norris; Frank-Erik de Leeuw
Journal:  Hum Brain Mapp       Date:  2015-10-15       Impact factor: 5.038

Review 8.  Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain.

Authors:  Teri A Manolio; Jean Olson; W T Longstreth
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

9.  Structural network efficiency predicts conversion to dementia.

Authors:  Anil M Tuladhar; Ingeborg W M van Uden; Loes C A Rutten-Jacobs; Andrew Lawrence; Helena van der Holst; Anouk van Norden; Karlijn de Laat; Ewoud van Dijk; Jurgen A H R Claassen; Roy P C Kessels; Hugh S Markus; David G Norris; Frank-Erik de Leeuw
Journal:  Neurology       Date:  2016-02-17       Impact factor: 9.910

10.  Cerebral small vessel disease and incident parkinsonism: The RUN DMC study.

Authors:  Helena M van der Holst; Inge W M van Uden; Anil M Tuladhar; Karlijn F de Laat; Anouk G W van Norden; David G Norris; Ewoud J van Dijk; Rianne A J Esselink; Bram Platel; Frank-Erik de Leeuw
Journal:  Neurology       Date:  2015-10-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.